Copyright
©The Author(s) 2025.
World J Methodol. Mar 20, 2025; 15(1): 95857
Published online Mar 20, 2025. doi: 10.5662/wjm.v15.i1.95857
Published online Mar 20, 2025. doi: 10.5662/wjm.v15.i1.95857
Complications | Administration | ||||||
1st | 2nd | 3rd | 4th | 5th | 6th | ||
Early | Infection | - | - | - | - | - | - |
Fever | - | + | + | - | - | - | |
Pain | + | - | - | - | - | - | |
Headache | - | - | - | - | + | - | |
Increased C-reactive protein levels | - | - | - | - | - | - | |
Leukocytosis | - | - | - | - | - | - | |
Allergic reaction or shock | - | - | - | - | - | - | |
Perioperative complications | - | - | - | - | - | - | |
Late | Secondary infections | - | - | - | - | - | - |
Urinary tract infections | - | - | - | - | - | - | |
Deterioration of neurological status | - | - | - | - | - | - | |
Neuropathic pain | - | - | - | - | - | - | |
Carcinogenesis | - | - | - | - | - | - |
- Citation: Kabatas S, Civelek E, Savrunlu EC, Karaaslan U, Yıldız Ö, Karaöz E. Advances in the treatment of autism spectrum disorder: Wharton jelly mesenchymal stem cell transplantation. World J Methodol 2025; 15(1): 95857
- URL: https://www.wjgnet.com/2222-0682/full/v15/i1/95857.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i1.95857